Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 10, 2005, Pages 544-548

  Cooper, Leslie T ^a,b   Zehr, Kenton J ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Eosinophilic myocarditis; Heart failure; Myocarditis; Ventricular assist device

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; CREATINE KINASE; DIURETIC AGENT; ESTROGEN; ILLICIT DRUG; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; TROPONIN T;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ANKLE FRACTURE; ANOREXIA; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CIGARETTE SMOKING; CREATINE KINASE BLOOD LEVEL; DIZZINESS; DRUG USE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; HEART ASSIST DEVICE; HEART DISEASE; HEART MUSCLE BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MENOPAUSAL SYNDROME; MYOCARDITIS; NAUSEA; NECROTIZING EOSINOPHILIC MYOCARDITIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNCOPE; THORAX PAIN; THORAX RADIOGRAPHY; URINARY TRACT INFECTION;

CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EOSINOPHILIA; FEMALE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYOCARDITIS; NECROSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 27944471407     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0322     Document Type: Article

References (14)

1. Herzog C et al. (1984) Acute necrotising eosinophilic myocarditis. Br Heart J 52: 343-348
2. Getz M et al. (1991) Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis antemortem diagnosis and successful treatment. Ann Intern Med 115: 201-202
3. deMello DE et al. (1990) Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med 323: 1542-1545
4. Corradi D et al. (2004) Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: Insights into mechanisms of myocardial cell death. Hum Pathol 35: 1160-1163
5. Adsett M et al. (2003) Eosinophilic heart: Marked left ventricular wall thickening and myocardial dysfunction improving with corticosteroid therapy. Echocardiography 20: 369-374
6. Kazama R et al. (2003) Therapeutic role of pericardiocentesis for acute necrotizing eosinophilic myocarditis with cardiac tamponade. Mayo Clin Proc 78: 901-907
7. Chun W et al. (2004) Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation 110: E19
8. Morimoto S et al. (2003) Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis. Heart Vessels 18: 193-196
9. Takkenberg J et al. (2004) Eosinophilic myocarditis in patients awaiting heart transplantation. Crit Care Med 32: 714-721
10. McCarthy RE et al. (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. New Engl J Med 342: 690-695
11. Fleming HA (1994) Cardiac sarcoidosis. Lung Biol Health Dis 73: 323-334
12. Sekiguchi M et al. (1996) Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 10: 495-510
13. Okura Y et al. (2003) A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41: 322-328
14. Cooper L et al. (2001) Survival in biopsy-proven cardiac sarcoidosis is similar to survival in lymphocytic myocarditis and dilated cardiomyopathy. In Proceeding of the Second International Congress on Heart Disease, 491-496 (Ed Kimchi A) New Jersey: Medimond